BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 10673979)

  • 1. Paediatric Hodgkin's disease.
    Pötter R
    Eur J Cancer; 1999 Oct; 35(10):1466-74; discussion 1474-6. PubMed ID: 10673979
    [No Abstract]   [Full Text] [Related]  

  • 2. Substaging of stage III Hodgkin's disease.
    Farah R; Weichselbaum RR
    Hematol Oncol Clin North Am; 1989 Jun; 3(2):277-86. PubMed ID: 2663828
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New therapies in Hodgkin's lymphoma.
    Bartlett N
    Clin Adv Hematol Oncol; 2004 Feb; 2(2):80, 83. PubMed ID: 16163165
    [No Abstract]   [Full Text] [Related]  

  • 4. Importance of substaging of stage III Hodgkin's disease.
    Golomb HM; Sweet DL; Ultmann JE; Miller JB; Kinzie JJ; Gordon LI
    Semin Oncol; 1980 Jun; 7(2):136-43. PubMed ID: 7444470
    [No Abstract]   [Full Text] [Related]  

  • 5. Pelvic relapse following subtotal lymphoid irradiation in early stage Hodgkin's disease--an analysis of risk, management, and outcome.
    Tate DJ; Hoppe RT
    Int J Radiat Oncol Biol Phys; 1995 Jul; 32(4):1239-44. PubMed ID: 7607947
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The management of Hodgkin's disease in relapse after primary radiation therapy.
    Hoppe RT
    Eur J Cancer; 1992; 28A(11):1920-2. PubMed ID: 1389536
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Are pelvic irradiation and routine staging laparotomy necessary in clinically staged IA and IIA Hodgkin's disease?
    Griffin T; Gerdes A; Parker R; Taylor E; Hafermann M; Taylor W; Tesh D
    Cancer; 1977 Dec; 40(6):2914-6. PubMed ID: 412583
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does bulky disease at diagnosis influence outcome in childhood Hodgkin's disease and require higher radiation doses? Results from the German-Austrian Pediatric Multicenter Trial DAL-HD-90.
    Dieckmann K; Pötter R; Hofmann J; Heinzl H; Wagner W; Schellong G;
    Int J Radiat Oncol Biol Phys; 2003 Jul; 56(3):644-52. PubMed ID: 12788169
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term follow-up of patients treated with primary radiotherapy for supradiaphragmatic Hodgkin's disease at St. Jude Children's Research Hospital.
    Shah AB; Hudson MM; Poquette CA; Luo X; Wilimas JA; Kun LE
    Int J Radiat Oncol Biol Phys; 1999 Jul; 44(4):867-77. PubMed ID: 10386644
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The need for long-term surveillance for patients treated with curative radiotherapy for Hodgkin's disease: University of Minnesota experience.
    Lee CK; Aeppli D; Nierengarten ME
    Int J Radiat Oncol Biol Phys; 2000 Aug; 48(1):169-79. PubMed ID: 10924987
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hodgkin's disease in elderly patients (> or =60): clinical outcome and treatment strategies.
    Kim HK; Silver B; Li S; Neuberg D; Mauch P
    Int J Radiat Oncol Biol Phys; 2003 Jun; 56(2):556-60. PubMed ID: 12738333
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The staging and treatment of Hodgkin's disease.
    Aisenberg AC
    N Engl J Med; 1978 Nov; 299(22):1228-32. PubMed ID: 362199
    [No Abstract]   [Full Text] [Related]  

  • 13. [Therapy of Hodgkin's disease].
    Fischer M; Mitrou PS
    Dtsch Med Wochenschr; 1979 Oct; 104(41):1450-7. PubMed ID: 385278
    [No Abstract]   [Full Text] [Related]  

  • 14. [The role of radiotherapy in the treatment of Stage IIIA Hodgkin's disease in children].
    Kanaev SV; Kolygin BA; Malinin AP; Chikrizov SI
    Vopr Onkol; 1986; 32(9):53-6. PubMed ID: 3765524
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term outcome of treatment for Ann Arbor stage 1 Hodgkin's disease: patterns of failure, late toxicity and second malignancies.
    Vlachaki MT; Ha CS; Hagemeister FB; Fuller LM; Rodriguez MA; Besa PC; Hess MA; Brown B; Cabanillas F; Cox JD
    Int J Radiat Oncol Biol Phys; 1997 Oct; 39(3):609-16. PubMed ID: 9336140
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hodgkin's disease: treatment with low dose radiation and chemotherapy.
    Donaldson SS
    Front Radiat Ther Oncol; 1981; 16():122-33. PubMed ID: 7333475
    [No Abstract]   [Full Text] [Related]  

  • 17. [The treatment of patients with refractory forms of Hodgkin's lymphomas].
    Hubareva HO; Kriachok IA; Tytorenko IB; Aleksyk OM; Novosad OI; Kadnikova TV; Martynchyk AV; Pastushenko IaV; Filonenko KS; Kushchevyĭ IeV
    Lik Sprava; 2010; (1-2):115-8. PubMed ID: 20608037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Recurrence of Hodgkin's disease after advanced primary stages. German Hodgkin's Study Group].
    Fuchs R; Löffler M; Pfreundschuh M; Dölken G; Gerhartz H; Hagen-Aukamp U; Hiller E; Petsch S; Pflüger KH; Rühl U
    Med Klin (Munich); 1992 Nov; 87(11):555-62. PubMed ID: 1281905
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reducing the toxicity of the combined modality therapy of favourable stage Hodgkin's disease.
    Rosenberg SA
    Eur J Cancer; 1992; 28A(8-9):1379-80. PubMed ID: 1515253
    [No Abstract]   [Full Text] [Related]  

  • 20. [Feasibility study of application of international prognostic score on prediction of prognosis for advanced Hodgkin's lymphoma].
    Fu XH; Wang SS; Huang Y; Wang B; Huang HQ; Zhang L; Sun XF; Xu RH; Lin TY
    Ai Zheng; 2006 Aug; 25(8):1013-8. PubMed ID: 16965685
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.